Insulin Detemir
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01307 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 13 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | type 1 diabetes mellitus | KG + DL |
| 2 | autoimmune oophoritis | KG + DL |
| 3 | opsismodysplasia | KG + DL |
| 4 | thiamine-responsive dysfunction syndrome | KG + DL |
| 5 | focal stiff limb syndrome | KG + DL |
| 6 | classic stiff person syndrome | KG + DL |
| 7 | pancreatic agenesis | KG + DL |
| 8 | drug-induced localized lipodystrophy | KG + DL |
| 9 | centrifugal lipodystrophy | KG + DL |
| 10 | pressure-induced localized lipoatrophy | KG + DL |
| 11 | idiopathic localized lipodystrophy | KG + DL |
| 12 | permanent neonatal diabetes mellitus | KG + DL |
| 13 | diabetes mellitus, insulin-dependent, X-linked, susceptibility to | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.